DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

Brain - Tập 133 Số 3 - Trang 713-726 - 2010
Zhen Hong1,2, Min Shi2, Kathryn A. Chung3, Joseph F. Quinn3, Elaine R. Peskind4,5, Douglas Galasko6, Joseph Jankovic7, Cyrus P. Zabetian8,5, James B. Leverenz8,4,5, Geoffrey S. Baird9, Thomas J. Montine2, Aneeka M. Hancock2, Hye‐Jin Hwang2, Catherine Pan2, Joshua M. Bradner2, Un Jung Kang10, Poul Henning Jensen11, Jing Zhang2
1Department of Neurology, West China Medical School, Sichuan University, Chengdu, Sichuan, China
2Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA
3Department of Neurology, Oregon Health and Science University, Portland, OR, USA
4Department of Psychiatry and Behavioural Sciences, University of Washington School of Medicine, Seattle, WA, USA
5Mental Illness Research, Education, and Clinical Centre, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
6Department of Neurosciences, University of California at San Diego, San Diego, CA, USA
7Parkinson’s Disease Centre and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA
8Department of Neurology, University of Washington School of Medicine, Seattle, WA, USA
9Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA, USA
10Department of Neurology, University of Chicago, Chicago, IL, USA
11Department of Medical Biochemistry, University of Aarhus, Aarhus, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Amenta, 2000, Localization of dopamine receptor subtypes in systemic arteries, Clin Exp Hypertens, 22, 277, 10.1081/CEH-100100077

Borghi, 2000, Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's; disease and normal subjects, Neurosci Lett, 287, 65, 10.1016/S0304-3940(00)01153-8

Braak, 2003, Staging of brain pathology related to sporadic Parkinson's; disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9

Burn, 2002, Progressive supranuclear palsy: where are we now?, Lancet Neurol, 1, 359, 10.1016/S1474-4422(02)00161-8

Choi, 2006, Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases, J Biol Chem, 281, 10816, 10.1074/jbc.M509079200

Dupont, 2005, Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants, J Reprod Immunol, 66, 175, 10.1016/j.jri.2005.03.005

El-Agnaf, 2006, Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's; disease, Faseb J, 20, 419, 10.1096/fj.03-1449com

Fahn, 2004, Levodopa and the progression of Parkinson's; disease, N Engl J Med, 351, 2498, 10.1056/NEJMoa033447

Fjorback, 2007, Determination of alpha-synuclein concentration in human plasma using ELISA, Scand J Clin Lab Invest, 67, 431, 10.1080/00365510601161497

Galvin, 2001, Synucleinopathies: clinical and pathological implications, Arch Neurol, 58, 186, 10.1001/archneur.58.2.186

Hansson, 2006, Association between CSF biomarkers and incipient Alzheimer's; disease in patients with mild cognitive impairment: a follow-up study, Lancet Neurol, 5, 228, 10.1016/S1474-4422(06)70355-6

Hong, 2009, Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth, J Proteome Res, 8, 2768, 10.1021/pr801052v

Jin, 2007, Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells, BMC Neurosci, 8, 67, 10.1186/1471-2202-8-67

Lee, 2006, The plasma alpha-synuclein levels in patients with Parkinson's; disease and multiple system atrophy, J Neural Transm, 113, 1435, 10.1007/s00702-005-0427-9

Li, 2002, Platelet al.ha- and gamma-synucleins in Parkinson's; disease and normal control subjects, J Alzheimers Dis, 4, 309, 10.3233/JAD-2002-4406

Li, 2007, Plasma alpha-synuclein is decreased in subjects with Parkinson's; disease, Exp Neurol, 204, 583, 10.1016/j.expneurol.2006.12.006

Lindersson, 2004, Proteasomal inhibition by alpha-synuclein filaments and oligomers, J Biol Chem, 279, 12924, 10.1074/jbc.M306390200

Liu, 2008, Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies, J Proteome Res, 7, 2033, 10.1021/pr7007779

Lucking, 2000, Alpha-synuclein and Parkinson's; disease, Cell Mol Life Sci, 57, 1894, 10.1007/PL00000671

Maita, 2008, Secretion of DJ-1 into the serum of patients with Parkinson's; disease, Neurosci Lett, 431, 86, 10.1016/j.neulet.2007.11.027

Meulener, 2005, DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein, J Neurochem, 93, 1524, 10.1111/j.1471-4159.2005.03145.x

Michell, 2005, Skin and platelet al.ha-synuclein as peripheral biomarkers of Parkinson's; disease, Neurosci Lett, 381, 294, 10.1016/j.neulet.2005.02.030

Mollenhauer, 2008, Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration, Exp Neurol, 213, 315, 10.1016/j.expneurol.2008.06.004

Mollenhauer, 2006, Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's; disease dementia, Dement Geriatr Cogn Disord, 22, 200, 10.1159/000094871

Nural, 2009, Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's; disease patients, Mol Neurodegener, 4, 23, 10.1186/1750-1326-4-23

Öhrfelt, 2009, Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?, Neurosci Lett, 450, 332, 10.1016/j.neulet.2008.11.015

Spies, 2009, Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders, J Alzheimers Dis, 16, 363, 10.3233/JAD-2009-0955

Tokuda, 2006, Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's; disease, Biochem Biophys Res Commun, 349, 162, 10.1016/j.bbrc.2006.08.024

van Geel, 2008, A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid, J Neurosci Methods, 168, 182, 10.1016/j.jneumeth.2007.09.021

Vignali, 2000, Multiplexed particle-based flow cytometric assays, J Immunol Methods, 243, 243, 10.1016/S0022-1759(00)00238-6

Waragai, 2007, Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's; disease, Neurosci Lett, 425, 18, 10.1016/j.neulet.2007.08.010

Waragai, 2006, Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's; disease, Biochem Biophys Res Commun, 345, 967, 10.1016/j.bbrc.2006.05.011

Westerlund, 2008, Cerebellar alpha-synuclein levels are decreased in Parkinson's; disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material, Faseb J, 22, 3509, 10.1096/fj.08-110148

Thông tin
Thông tin xuất bản

Brain

Tập 133 Số 3

713-726

Thông tin tác giả